Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | New Visiongain Report: Attention Deficit Hyperactivity Disorder Drugs Market Forecast to 2029"Global Attention Deficit Hyperactivity Disorder Drugs Market is estimated to reach $17bn by 2024"
By: Visiongain The global attention deficit hyperactivity disorder is anticipated to witness strong growth during the forecast period. Factors such as the growing prevalence of the ADHD cases in adults and children, growing awareness coupled with support from the government as well as rising regulatory approvals will drive market growth. The lead analyst of the report commented "The global attention deficit disorder market is one that is driven by innovation. This is vital for maintaining the rich pipeline of ADHD drugs seen in the market today. There is increasing focus to identify and treat ADHD that currently are undertreated and try to serve these neglected markets. This creates a strong platform for both start-ups and larger pharmaceutical companies to create new drugs that are not already on the market. This prevents stagnation within the market and will help drive the growth of attention deficit disorder market." Purchase or download free sample pages: https://www.visiongain.com/ Leading companies featured in the report include Eli Lilly, Johnson and Johnson, Lupin Limited, Mallinckrodt & Co., Neos Therapeutics, Pfizer Inc., Purdue Pharma L.P., Takeda Pharmaceuticals and other companies. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|